| Graham TR, Yacoub R, Taliaferro-Smith L, et al.
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells. [JOURNAL ARTICLE]
Breast Cancer Res Treat 2009 Nov 18.
Abstract | Full Citation | Find Related Articles | | Miyamoto K, Kawai H, Aoyama R, et al.
Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice. [JOURNAL ARTICLE]
Clin Exp Nephrol 2009 Nov 14.
Abstract | Full Citation | Find Related Articles | | Wadhwa VK, Weston R, Parr NJ
Frequency of zoledronic acid to prevent further bone loss in osteoporotic patients undergoing androgen deprivation therapy for prostate cancer. [JOURNAL ARTICLE]
BJU Int 2009 Nov 13.
Abstract | Full Citation | Find Related Articles | | Quéro L, Giocanti N, Hennequin C, et al.
Antagonistic interaction between bicalutamide (Casodex(R)) and radiation in androgen-positive prostate cancer LNCaP cells. [JOURNAL ARTICLE]
Prostate 2009 Nov 9.
Abstract | Full Citation | | Ishikura N, Kawata H, Nishimoto A, et al.
Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10. [JOURNAL ARTICLE]
Prostate 2009 Nov 9.
Abstract | Full Citation | Find Related Articles | | Thomas MA, Preece DM, Bentel JM
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3'untranslated region. [JOURNAL ARTICLE]
Biochem J 2009 Nov 3.
Abstract | Full Citation | Find Related Articles | | Sabbatini P, Spriggs D, Aghajanian C, et al.
Consolidation strategies in ovarian cancer: Observations for future clinical trials. [JOURNAL ARTICLE]
Gynecol Oncol 2009 Oct 15.
Abstract | Full Citation | | Andrews GP, Abudiak OA, Jones DS
Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions. [JOURNAL ARTICLE]
J Pharm Sci 2009 Oct 1.
Abstract | Full Citation | | Sartor O, Gomella LG, Gagnier P, et al.
Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: The Therapy Assessed by Rising PSA (TARP) study rationale and design. [Journal Article]
Can J Urol 2009 Oct; 16(5):4806-12.
Abstract | Full Citation | Find Related Articles | | Terada N, Shimizu Y, Yoshida T, et al.
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft. [JOURNAL ARTICLE]
Prostate 2009 Sep 29.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
